Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20975794 | 1.00 | TSHR (0.37) | TSHROPRM1OPRL1HCRTR2 | |
| SCHEMBL19198740 | 0.83 | OPRM1 (0.41) | TSHROPRM1OPRL1 | |
| SCHEMBL19199097 | 0.81 | TSHR (0.33) | TSHR | |
| SCHEMBL19194332 | 0.74 | — | — | |
| SCHEMBL21162013 | 0.73 | TSHR (0.43) | TSHROPRM1OPRL1 | |
| SCHEMBL19194780 | 0.72 | — | — | |
| SCHEMBL19194779 | 0.72 | — | — | |
| SCHEMBL19199513 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL28320656 | 0.71 | TSHR (0.42) | TSHROPRM1OPRL1 | |
| SCHEMBL19250235 | 0.70 | TSHR (0.41) | TSHROPRM1OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170217974-A1 | HEPATITIS B ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2017-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170217974-A1 | HEPATITIS B ANTIVIRAL AGENTS | HAVCR2, ZC3HAV1, SLC10A1 | TSHR 2206/4885OPRM1 2525/4885OPRL1 4083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.